The Case for Expensive Antibiotics
A rogue pharmaceutical company ramped up the cost of a common antibiotic by 400 percent. While the medical community is irate, could high prices make antibiotics worth investing in?
-
Paul Pelosi released from hospital six days after hammer attack
November 3, 2022 -
'No state, no government': weary Lebanese mark 75 years of independence
November 22, 2018 -
Clips' Rivers rips challenge rule after foul stands
November 7, 2019
